Mineralys Therapeutics, Inc.首席医疗官David Malcom Rodman日前申报减持该公司普通股。根据最新披露文件，Rodman已完成对Mineralys Therapeutics股票的交易处置。完整交易记录可通过监管申报文件查阅。
（注：本资讯基于监管机构公开披露文件编制，仅供信息参考，不构成任何投资建议。原始文件由Mineralys Therapeutics, Inc.于2025年7月15日通过美国证券交易委员会EDGAR系统申报。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.